Australian national trends in stimulant dispensing: 2002–2009

References

• Greenhill LL, Pliszka S, Dulcan MK . Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002; 41S2:26–49.
   Google Scholar
• e Business Services Australian Register of Therapeutic Goods. Information about prescription medicines in Australia. [Cited 9 November 2011]. Available from URL https://www.ebs.tga.gov.au/
   Google Scholar
• Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep 2007; 30:13–26.
   PubMed Web of Science ®Google Scholar
• Sawyer MG, Arney FM, Baghurst PA . The mental health of young people in Australia: key findings from the child and adolescent component of the National Survey of Mental Health and Well-Being. Aust N Z J Psychiatry 2001; 35:806–814.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, Rohde LA. Epidemiology of attention deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry 2007; 20:386–392.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006; 36:159–165.
   PubMed Web of Science ®Google Scholar
• Donnelly M, Haby MM, Carter R, Andrews G, Vos T. Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder. Aust N Z J Psychiatry 2004; 38:592–601.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health. Attention deficit hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. NICE clinical guideline 72. London: National Institute for Health and Clinical Excellence, 2008.
   Google Scholar
• Knellwolf AL, Deligne J, Chiarotti F . Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol 2008; 64:311–317.
   PubMed Web of Science ®Google Scholar
• Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: a study from the Netherlands. Pediatrics 2001; 108:E25.
   PubMed Web of Science ®Google Scholar
• Habel LA, Schaefer CA, Levine P, Bhat AK, Elliott G. Treatment with stimulants among youths in a large California health plan. J Child Adolesc Psychopharmacol 2005; 15:62–67.
   PubMed Web of Science ®Google Scholar
• Vinker S, Vinker R, Elhayany A. Prevalence of methylphenidate use among Israeli children: 1998–2004. Clin Drug Investig 2006; 26:161–167.
   PubMed Web of Science ®Google Scholar
• Miller AR, Lalonde CE, McGrail KM, Armstrong RW. Prescription of methylphenidate to children and youth, 1990–1996. Can Med Assoc J 2001; 165:1489–1494.
   Web of Science ®Google Scholar
• Berbatis CG, Sunderland VB, Bulsara, M. Licit psychostimulant consumption in Australia, 1984–2000: international and jurisdictional comparison. Med J Aust 2002; 177:539–543.
   PubMed Web of Science ®Google Scholar
• Valentine J, Zubrick S, Sly P. National trends in the use of stimulant medication for attention deficit hyperactivity disorder. J Paediatr Child Health 1996; 32:223–227.
   PubMed Web of Science ®Google Scholar
• Salmelainen P. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales. NSW Public Health Bull Suppl 2002; 13:1–65.
   PubMedGoogle Scholar
• Salmelainen P. Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in NSW. NSW Public Health Bull Suppl 2004; 15:1–55.
   Google Scholar
• Calver J, Preen D, Bulsara M, Sanfilippo F. Stimulant prescribing for the treatment of ADHD in Western Australia: socioeconomic and remoteness differences. Med J Aust 2007; 186:124–127.
   PubMed Web of Science ®Google Scholar
• Prosser B, Reid R. Changes in use of psychostimulant medication for ADHD in South Australia (1990–2006). Aust N Z J Psychiatry 2009; 43:340–347.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health and Ageing. Australian statistics on medicines 2008. Canberra: Department of Health and Ageing, 2009.
   Google Scholar
• World Health Organization. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs, 2005. Oslo: WHO, 2005.
   Google Scholar
• Australian Bureau of Statistics. Population by age and sex, Australian states and territories, June 2002 to June 2009. (Cited 4 May 2010.) Available from URL http://www.abs.gov.au/AUSSTATS/[email protected]/MF/3201.0.
   Google Scholar
• Sterne JA, Davey Smith G. Sifting the evidence: what's wrong with significance tests? Br Med J 2001; 322:226–231.
   PubMed Web of Science ®Google Scholar
• Van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev 2008; 28:783–800.
   PubMed Web of Science ®Google Scholar
• Tobin L, de Almedia Neto AC, Wutzke S . Influences on the prescribing of new drugs. Aust Fam Physician 2008; 37:78–80.
   PubMedGoogle Scholar
• Levy F, Hay DA, Bennett KS, McStephen M. Gender differences in ADHD subtype comorbidity. J Am Acad Child Adolesc Psychiatry 2005; 44:368–376.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164:942–948.
   PubMed Web of Science ®Google Scholar
• Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA. Use of medication by young people with attention-deficit/hyperactivity disorder. Med J Aust 2002; 177:21–25.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Adler LA, Adams J . Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008; 47:21–31.
   PubMed Web of Science ®Google Scholar
• Candy M, Jones L, Williams R, Tookman A, King M. Psychostimulants for depression. Cochrane Database Syst Rev 2008; 2:CD006722.
   Google Scholar
• Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995; 152:929–931.
   PubMed Web of Science ®Google Scholar
• Adler LA, Spencer T, Brown TE . Once-daily atomoxetine for adult attention deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol 1999; 29:44–50.
   Google Scholar